East West Pharma at RSSDI Kerala Annual Conference 2025 – Advancing Insights in diabetic care
East West Pharma participated in the RSSDI (Research Society for the Study of Diabetes in India) Kerala Annual Conference, reinforcing our commitment to the diabetes care segment. Our presence at this prestigious event, held on 22nd & 23rd February, at Trivandrum, provided a platform to engage with leading diabetologists and healthcare professionals, strengthening our rapport with key opinion leaders (KOLs) and practitioners in the field.
Beyond the Usual – Adding Value to the Discourse
We elevated our participation by bringing in an eminent dermatologist as a speaker. Recognizing the increasing intersection between diabetes and dermatological issues, we facilitated a session on “Skin & Diabetes: Challenges and Answers.” The talk by Dr. Sebastian Criton, Prof & HOD, Department of Dermatology, Amla Institute of Medical Sciences, Thrissur, addressed the dermatological manifestations in diabetic patients and provided practical insights into their management.
East West Pharma’s display hub was designed to be an engaging and informative space, attracting significant footfall from leading diabetologists and healthcare professionals. Our setup went beyond just showcasing products—it was a hub for meaningful discussions on diabetes management, emerging challenges, and innovative treatment solutions. The display featured our comprehensive diabetes portfolio, emphasizing our commitment to addressing the multifaceted needs of diabetic patients. The stall had a footfall of more than 100 delegates.
East West Pharma’s participation in RSSDI Kerala was not just another conference presence—it was a step towards further value addition to an excellent academic discourse that focussed on emerging therapy trends. Engaging with esteemed diabetologists and healthcare professionals allowed us to showcase our evolving product portfolio and gain valuable insights for shaping a better tomorrow for both patients and HCPs through innovative solutions.